株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

細胞アッセイの世界市場:製品、技術、アプリケーション、エンドユーザー、地域別成長率、動向および予測(2018年~2023年)

Global Cell-Based Assay Market - Segmented by Product, Technology, Application, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)

発行 Mordor Intelligence LLP 商品コード 390837
出版日 ページ情報 英文 112 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.55円で換算しております。
Back to Top
細胞アッセイの世界市場:製品、技術、アプリケーション、エンドユーザー、地域別成長率、動向および予測(2018年~2023年) Global Cell-Based Assay Market - Segmented by Product, Technology, Application, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)
出版日: 2018年05月01日 ページ情報: 英文 112 Pages
概要

世界の細胞アッセイ市場は、2018年から2023年の予測期間中に8.2%のCAGRで成長する見込みです。細胞アッセイは、ヘルスケアにおける多目的な研究ラボツールで、薬物の機能性および有効性を決定するために、抗体または他の部分を用いて特定の細胞を標的とするように設計されています。 R&Dへの支出の増加、政府のイニシアティブの強化、技術革新の進展などは、北米が同市場を支配する助けとなっています。

当レポートでは、世界の細胞アッセイ市場を調査し、全体的な市場動向、製品・技術・アプリケーション・エンドユーザー・地域別の詳細動向、市場成長への影響要因の分析、競合情勢、主要企業のプロファイルなどを包括的にまとめています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響要因

第5章 市場の概要

  • 現在の市場シナリオ
  • ポーターのファイブフォース分析
    • サプライヤーの交渉力
    • 消費者の交渉力
    • 新規参入の脅威
    • 代替製品およびサービスの脅威
    • 業界内での競争

第6章 成長要因、阻害要因、機会、課題の分析(DROC)

  • 成長要因
    • 慢性疾患および生活習慣病の流行
    • 新薬発見のための研究開発における投資の増加
    • 細胞ベースの方法論における技術的進歩の高まり
    • ハイスループットスクリーニング法の採用の増加
  • 阻害要因
    • 高いメンテナンスと運用コスト
    • これらの技術を運用する熟練者の不足
    • 厳密な制御経路
  • 市場機会
  • 主な課題

第7章 市場セグメンテーション

  • 製品別
    • 細胞株
    • 試薬およびキット
    • メタルプレート
    • その他の消耗品
  • 技術別
    • 自動処理
    • フローサイトメトリー
    • ラベルフリー検出
    • ハイスループットスクリーニング
    • その他
  • アプリケーション別
    • 創薬
    • ADME研究
    • その他のアプリケーション
  • エンドユーザー
    • 学術機関
    • 製薬およびバイオテクノロジー企業
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第8章 競合情勢

  • M&A分析
  • 合意、コラボレーション、パートナーシップ
  • 新製品の発売

第9章 主要企業

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Corning, Inc.
  • Danaher Corporation
  • DiscoverX Corporation
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • Perkin Elmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.
  • その他

第10章 市場の将来展望

目次
Product Code: 52690

The global cell-based assay market is expected to register a CAGR of 8.2% during the forecast period of 2018-2023. Cell-based assays are versatile research lab tool in healthcare, designed to target specific cells using antibodies or other moieties, to determine the functionality and efficacy of drugs. The higher expenditure on R&D, favorable government initiatives, and more technological advancements help North America to dominate this market.

Rising Chronic Diseases and Lifestyle Disorders

The rising prevalence of chronic diseases and lifestyle disorders, such as cancer, arthritis, cardiovascular, diabetes, and epilepsy, is one of the primary factors for the growth of this market. The cell-based assays for nervous system and chronic pain drug discovery provide new opportunities in the search for novel medicines for neurodegenerative diseases and pain. Cell-based assays are highly useful in screening mutagenesis in case of various types of cancers, such as chronic myeloid leukemia. According to the Center for Disease Control and Prevention, seven of the top 10 diseases in 2014 were chronic diseases. Thus, the rise in chronic diseases provides rising demand for cell-based assays for newer drug discoveries, making it a vital factor for the growth of this market.

Other factors playing a vital role for the growth of this market include increasing investments in R&D for drug discovery, technological advancements in cell-based methodologies, and rising adoption of high-throughput screening methods, particularly in toxicological studies.

High Maintenance and Operational Costs

One of the major factors restraining the cell-based assays market is the high maintenance of instruments and their operational costs. With the involvement of significant cost in operations, the market becomes less attractive in large-scale applications. For example, high cost associated with the CellKey system and RT-CES. With that, there is an increased cost for coated plates, which are not readily affordable. This forces several companies and research labs to find cost-effective alternatives, such as pre-treating of plates with collagen, thereby, impeding the growth of the market.

Along with this, other factors such as lack of skilled professionals and stringent regulatory pathways linked to instruments, reagents, and kits hamper the growth of this market.

United States to Hold the Largest Market Share

The United States is expected to have the largest market share in the forecast period. The dominance is primarily attributed to the rising availability of funds for research and extensive drug discovery activities in the country from multinational firms in collaborations with domestic companies and research institutes. The Asia-Pacific region also posses a potential market for the growth of cell-based assays due to a large patient pool, rising economies, and rising assays applications, with China and India being profitable markets.

Key Developments in the Market

February 2018: Imec, one of the leaders in nanoelectronics and digital technologies, designed and fabricated a 16,384-electrode, 1,024-channel micro-electrode array for high-throughput multi-modal cell interfacing.

January 2018: Agilent Technologies expanded its cell analysis portfolio by the acquisition of Luxcel Biosciences, involved in the development of real-time fluorescence plate-reader based on in-vitro cell assay kits.

Major players: BECTON, DICKINSON AND COMPANY, BIO-RAD LABORATORIES, INC., CORNING, INC., DANAHER CORPORATION, DISCOVERX CORPORATION, F. HOFFMANN-LA ROCHE LTD, MERCK KGAA, PERKIN ELMER, INC., PROMEGA CORPORATION, AND THERMO FISHER SCIENTIFIC, INC., amongst others.

Reasons to Purchase the Report

A look at the current and future of the global cell-based assays market in the developed and emerging regions.

Analyzing various perspectives of the market with the help of Porter's Five Forces Analysis.

Identify the segment that is expected to dominate the market.

Identify the regions that are expected to witness the fastest growth during the forecast period.

Identify the latest developments, market shares, and strategies employed by the major market players.

3 months analyst support along with the Market Estimate sheet (in Excel).

Customization of the Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.

Table of Contents

1. Introduction

  • 1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

  • 5.1 Current Market Scenario
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Consumers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitute Products and Services
    • 5.2.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

  • 6.1 Drivers
    • 6.1.1 Rising Prevalence of Chronic Diseases and Lifestyle Disorders
    • 6.1.2 Increasing Investments in Research and Development for Drug Discovery
    • 6.1.3 Rise in Technological Advancements in Cell-based Methodologies
    • 6.1.4 Rising Adoption of High-Throughput Screening Methods
  • 6.2 Restraints
    • 6.2.1 High Maintenance and Operational Costs
    • 6.2.2 Lack of Skilled Personnels to Operate these Technologies
    • 6.2.3 Stringent Regulatory Pathways
  • 6.3 Opportunities
  • 6.4 Key Challenges

7. Market Segmentation

  • 7.1 By Product
    • 7.1.1 Cell Lines
      • 7.1.1.1 Primary Cell Lines
      • 7.1.1.2 Stem Cell Lines
      • 7.1.1.3 Others
    • 7.1.2 Reagents and Kits
    • 7.1.3 Mircoplates
    • 7.1.4 Other Consumables
  • 7.2 By Technology
    • 7.2.1 Automated Handling
    • 7.2.2 Flow Cytometry
    • 7.2.3 Label-Free Detection
    • 7.2.4 High-Throughput Screening
    • 7.2.5 Others
  • 7.3 By Application
    • 7.3.1 Drug Discovery
    • 7.3.2 ADME Studies
    • 7.3.3 Other Applications
  • 7.4 By End User
    • 7.4.1 Academia
    • 7.4.2 Pharmaceutical and Biotechnology Companies
    • 7.4.3 Others
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States
      • 7.5.1.2 Canada
      • 7.5.1.3 Mexico
      • 7.5.1.4 Rest of North America
    • 7.5.2 Europe
      • 7.5.2.1 France
      • 7.5.2.2 Germany
      • 7.5.2.3 United Kingdom
      • 7.5.2.4 Italy
      • 7.5.2.5 Spain
      • 7.5.2.6 Rest of Europe
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China
      • 7.5.3.2 Japan
      • 7.5.3.3 India
      • 7.5.3.4 Australia
      • 7.5.3.5 South Korea
      • 7.5.3.6 Rest of Asia-Pacific
    • 7.5.4 Middle East & Africa
      • 7.5.4.1 GCC
      • 7.5.4.2 South Africa
      • 7.5.4.3 Rest of the Middle East & Africa
    • 7.5.5 South America
      • 7.5.5.1 Brazil
      • 7.5.5.2 Argentina
      • 7.5.5.3 Rest of South America

8. Competitive Landscape

  • 8.1 Mergers & Acquisition Analysis
  • 8.2 Agreements, Collaborations, and Partnerships
  • 8.3 New Products Launches

9. Key Players

  • 9.1 Becton, Dickinson and Company
  • 9.2 Bio-Rad Laboratories, Inc.
  • 9.3 Corning, Inc.
  • 9.4 Danaher Corporation
  • 9.5 DiscoverX Corporation
  • 9.6 F. Hoffmann-La Roche Ltd
  • 9.7 Merck KGaA
  • 9.8 Perkin Elmer, Inc.
  • 9.9 Promega Corporation
  • 9.10 Thermo Fisher Scientific, Inc.
  • 9.11 List not Exhaustive

10. Future of the Market

Back to Top